Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00953732 · ClinicalTrials.gov registry record
A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
A clinical trial of Actinic Keratosis, sponsored by Peplin.
- Completed
- Registry status
- 117
- Enrollment target
- 20
- Study locations
NCT00953732 is a study of Actinic Keratosis that has completed, run by Peplin. The registered enrollment target is 117 participants, below the 182-participant average among 16 other Actinic Keratosis trials with a reported enrollment target (36% lower). The trial reports 20 study locations across 10 states.
The verdict
NCT00953732, a study of Actinic Keratosis, has completed, sponsored by Peplin.
- COMPLETED
- Registry status
- 117 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is designed to follow up patients who have achieved complete clearance of AK lesions at the Day 57 visit having completed the PEP005-016 or PEP005-025 studies over a 12 month period to assess both recurrence of Actinic Keratosis (AK) lesions and long term safety in the selected treatment area.
Conditions Studied
Interventions
- DRUG Lesion count
Study Locations (20)
California
- Center for Dermatology - Fremont
- Dermatology Research Associates - Los Angeles
- Dermatology Specialists Inc - Oceanside
- Skin Surgery Medical Group Inc. - San Diego
- Conant Medical Group - San Francisco
Indiana
- Laser Skin Surgery Center of Indiana - Carmel
- Deaconess Clinic, Inc - Evansville
- Dawes Fretein Clinical Research Group, LLC - Indianapolis
- The Indiana Clinical Trials Center, PC - Plainfield
Florida
- North Florida Dermatology Associates, PA - Jacksonville
- University of Miami, Skin Research Camp - Miami
Georgia
- Atlanta Dermatology, Vein & Research Center, LLC - Alpharetta
- Medaphase Inc - Newnan
Illinois
- Altman Dermatology Associates - Arlington Heights
- Glazer Dermatology - Buffalo Grove
Arizona
- Burke Pharmaceutical Research - Hot Springs
Kentucky
- Pedia Research LLC - Owensboro
Michigan
- Hamzavi Dermatology - Fort Gratiot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2009-08 |
| Est. Completion | 2010-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00953732
The ClinicalTrials.gov registry entry for NCT00953732 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 182-participant average among 16 other Actinic Keratosis trials with a reported enrollment target (36% lower). The listed sponsor is Peplin, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Actinic Keratosis appearing as the primary indexed condition, and to 1 intervention - of which Lesion count is the first listed.
NCT00953732 reports 20 study locations spanning 10 distinct geographic areas - top geographies include California, Indiana, Florida.
Frequently Asked Questions
What is clinical trial NCT00953732 about?
NCT00953732 is a clinical study titled "A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies". This study is designed to follow up patients who have achieved complete clearance of AK lesions at the Day 57 visit having completed the PEP005-016 or PEP005-025 studies over a 12 month period to assess both recurrence of Actinic Keratosis (AK) lesions and long term safety in the selected treatment ...
What is the current status of trial NCT00953732?
This trial is currently completed. The enrollment target is 117 participants. The study started on 2009-08. Estimated completion is 2010-10.
What conditions does trial NCT00953732 study?
This clinical trial studies the following conditions: Actinic Keratosis.
What interventions are being tested in trial NCT00953732?
The interventions under investigation include: Lesion count (DRUG).
Who is sponsoring clinical trial NCT00953732?
This trial is sponsored by Peplin, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00953732 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Actinic Keratosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans
RECRUITING · Phase 2
-
The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy
RECRUITING · Phase 1
-
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp
ACTIVE NOT RECRUITING · Phase 3
-
Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities
ACTIVE NOT RECRUITING · Phase 3
-
Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients
ACTIVE NOT RECRUITING · Phase 2
-
Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.